Pharsight
Ask Pharsight
TCR2 THERAPEUTICS INC PATENTS FACING OPPOSITIONS
Top patents of TCR2 THERAPEUTICS INC facing oppositions at the European Patent Office (EPO)
Activity Alert
Get e-mail alerts for changes to below patents
Patent Number
Grant Date
Patent Title
Expected Expiration Date
Facing Oppositions
Activity Alert
EP3298033B2
12 Jul, 2023
Compositions And Methods For Tcr Reprogramming Using Fusion Proteins
May, 2036
1